Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seliger

Showing results (11-20 of 304) with videos related to

Pageof 31
Sort By:
Cancer Immunology, Immunotherapy : CII|November 13, 2024
"Tumor immunology meets oncology" (TIMO), 18 April-20 April 2024, in Brandenburg an der Havel, GermanyBarbara Seliger
Cancer Immunology, Immunotherapy : CII|November 29, 2011
Novel insights into the molecular mechanisms of HLA class I abnormalitiesBarbara Seliger
Journal of Immunotoxicology|May 1, 2009
Different regulation of MHC class I antigen processing components in human tumorsBarbara Seliger
Frontiers in Immunology|September 27, 2019
The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment-ReviewBarbara Seliger
Journal of Immunotoxicology|February 1, 2014
The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factorsBarbara Seliger
Cancer Immunology, Immunotherapy : CII|April 15, 2008
Molecular mechanisms of MHC class I abnormalities and APM components in human tumorsBarbara Seliger
Human Immunology|March 30, 2024
Role of HLA-G in tumors and upon COVID-19 infectionBarbara Seliger
Seminars in Cancer Biology|August 21, 2007
Structure, expression and function of HLA-G in renal cell carcinomaBarbara Seliger, Gerald Schlaf
Current Cancer Drug Targets|July 10, 2018
Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' OutcomeKarthikeyan Subbarayan, Barbara Seliger
Journal of Translational Medicine|May 7, 2026
Interferon lambda in anti-viral defense and cancer: dual roles, mechanism and therapeutic potentialJuliane Blümke, Barbara Seliger
Pageof 31

Showing results (11-20 of 304) with videos related to

Sort By:
Pageof 31
Cancer Immunology, Immunotherapy : CII|November 13, 2024
"Tumor immunology meets oncology" (TIMO), 18 April-20 April 2024, in Brandenburg an der Havel, GermanyBarbara Seliger
Cancer Immunology, Immunotherapy : CII|November 29, 2011
Novel insights into the molecular mechanisms of HLA class I abnormalitiesBarbara Seliger
Journal of Immunotoxicology|May 1, 2009
Different regulation of MHC class I antigen processing components in human tumorsBarbara Seliger
Frontiers in Immunology|September 27, 2019
The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment-ReviewBarbara Seliger
Journal of Immunotoxicology|February 1, 2014
The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factorsBarbara Seliger
Cancer Immunology, Immunotherapy : CII|April 15, 2008
Molecular mechanisms of MHC class I abnormalities and APM components in human tumorsBarbara Seliger
Human Immunology|March 30, 2024
Role of HLA-G in tumors and upon COVID-19 infectionBarbara Seliger
Seminars in Cancer Biology|August 21, 2007
Structure, expression and function of HLA-G in renal cell carcinomaBarbara Seliger, Gerald Schlaf
Current Cancer Drug Targets|July 10, 2018
Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' OutcomeKarthikeyan Subbarayan, Barbara Seliger
Journal of Translational Medicine|May 7, 2026
Interferon lambda in anti-viral defense and cancer: dual roles, mechanism and therapeutic potentialJuliane Blümke, Barbara Seliger
Pageof 31